STUDY OF PRESCRIPTION PATTERN OF ANTIEPILEPTICS DRUGS USED IN GSVM MEDICAL COLLEGE, KANPUR; A TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Prescription, Anti-epileptics Drugs, Tertiary care hospital
Abstract
Introduction: Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked seizures that can significantly impact an individual's quality of life. Current evidence suggests that the prescription of AEDs can vary significantly based on factors such as the type of epilepsy, patient demographics, and the presence of comorbid conditions.
Aims & Objectives: The study aims to analyse prescription pattern of antiepileptic drugs used in Neuro medicine department of the tertiary care hospital, GSVM Medical College Kanpur, Uttar Pradesh.
Material & Methods: An observational, cross-sectional study was carried out in Department of Pharmacology in collaboration with the Department of Neurology, G.S.V.M Medical College, Kanpur. Prescriptions of study participants were collected and further studied. All basic details and prescribed drugs were collected and entered in predesigned proforma.
Results: It is observed that in 136 study subjects ‘prescriptions, the total number of prescribed antiepileptic drugs in study prescriptions was found to be 479 and the average number of prescribed antiepileptics per prescription encounter was found 3.52. It was observed that four fifth (79.41%) drugs were prescribed in polytherapy form i.e. more than two drugs and one fifth (20.59%) antiepileptics prescribed as monotherapy for management of diagnosed epilepsy diseases/disorders in study patients. Out of the total prescribed antiepileptic drugs, the most commonly prescribed antiepileptic drug was Carbamazepine (31.94%) followed by sodium valproate (23.59%) and Levetiracetam (21.29%).
Conclusion: Overall, this study serves as a foundational assessment of AED prescribing practices at GSVM Medical College, Kanpur, and provides a basis for ongoing improvements in epilepsy management. By addressing the identified limitations and implementing the suggested recommendations, the institution can work towards optimizing patient care and aligning its practices with the latest advancements in epilepsy treatment
References
2. Radhakrishnan, A., 2016. Bridging the treatment gap in epilepsy-is there an emerging trend in the use of newer antiepileptic drugs?. Neurology India, 64(6), 1140-1142.
3. Sirven JI, Noe K, Hoerth M, Drazkowski J. Antiepileptic drugs: Recent advances and trends. Mayo Clin Proc. 2012;87:879-89.
4. Sharma R, Khajuria R, Sharma P, Sadhotra P, Kapoor B, Kohli K, et al. Glaucoma therapy: prescribing pattern and cost analysis. JK Science. 2004;6(2):88- 92.
5. Ahmad A, Khan MU, Patel I, Maharaj S, Pandey S, Dhingra S. Knowledge, attitude and practice of B.Sc.Pharmacy students about antibiotics in Trinidad and Tobago. J Res Pharm Prac.2015;4(1):37-41.
6. Kwan, P., & Brodie, M. J. (2000). "Early identification of refractory epilepsy." New England Journal of Medicine, 342(5), 314-319. doi:10.1056/NEJM200002033420503.
7. Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., et al. (2007). "The SANAD trial: A randomised trial of the efficacy and cost-effectiveness of different antiepileptic drugs." The Lancet Neurology, 6(6), 511-518. doi:10.1016/S1474-4422(07)70138-1.
8. Hermann, B. P., & Seidenberg, M. (2007). "The neurobehavioral impact of epilepsy and antiepileptic drugs." Epilepsy & Behavior, 10(2), 233-236. doi:10.1016/j.yebeh.2007.07.023.
9. Perucca, E., & Tomson, T. (2011). "The pharmacological treatment of epilepsy in adults." The Lancet Neurology, 10(5), 446-456. doi:10.1016/S1474-4422(11)70040-2.
10. Simoens S. Health economic assessment: a methodological primer. Int J Environ Res Public Health 2009;6:2950-66.
11. Brodie MJ, Chung S, Wade A, Quelen C, Guiraud-Diawara A, François C, Verpillat P, Shen V, Isojarvi J. Clobazam and clonazepam use in epilepsy: results from a UK database incident user cohort study. Epilepsy Research. 2016 Jul 1;123:68-74.
12. François C, Stern JM, Ogbonnaya A, Lokhandwala T, Landsman- Blumberg P, Duhig A, Shen V, Tan R. Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome. Journal of market access & health policy. 2017 Jan 1;5(1):1318691.
13. Lekshmi AA Lekshmi AA, Anjana A, Emmanuel SM, Sreelekshmi V, Selvin CDS. Evaluation of Prescribing Pattern of Antiepileptic Drugs and Assessment of Quality of Life of Epileptic Patients and the Knowledge of Their Care Givers. J App Pharm Sci, 2017; 7 (10): 152-156
14. Nunley S, Glynn P, Rust S, Vidaurre J, Albert DV, Patel AD. Healthcare utilization characteristics for intranasal midazolam versus rectal diazepam. Journal of child neurology. 2018 Feb;33(2):158-63.
15. Acton EK, Gelfand MA, Hennessy S, Xie SX, Pollard JR, Kasner SE, Willis AW. Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010–2018. Epilepsy & Behavior. 2020 Dec 1; 113:107550.’
16. Sarangi SC, Kaur N, Tripathi; Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy; Saudi Pharmaceutical Journal 28 (2020) 1228–1237
17. Perween N , Kumari A , Kumari V; A Hospital Based Observational Study to Evaluate the Prescription Pattern of Antiepileptic Drugs; International Journal of Pharmaceutical and Clinical Research 2023; 15(3); 1152-1156
18. Ray BK, Bhattacharya S, Kundu TN, Saha SR Das SK. Epidemiology of epilepsy – Indian Perspective. J Ind Med Assoc 2002; 100: 322–26.
19. Caprio A and Hauser WA. Epilepsy in the developing world. Curr Neurol Sci Rep 2009; 9(4): 319-26.
20. Hanssen Y, Dulue D, Al Balushi K, Al Hashar A and Al Zakwani I. Drug utilization pattern of anti-epileptic drugs: a pharmaco epidemiologic study in Oman. Journal of Clinical Pharmacy and Therapeutics 2002; 27: 357-64.
21. Lim SH and Tan EK. Pattern of antiepileptic drug usage in a tertiary referral hospital in Singapore. Neurol J Southeast Asia 1997; 2: 77-85.
22. Murthy VN, Anusha B and Perumal P. A Study on trends in prescribing pattern of antiepileptic drugs in tertiary care teaching hospital. Int J of Chemical & Pharma Sci 2012; 3(2): 25-32.
23. Badwaik TR, Mahajan MH, Borker SA, Honrao R and Chopade SS. A drug utilization study of antiepileptic drugs use in a tertiary care hospital of central India. J Cont Med a Dent 2015; 3(2):33-38.
24. Begley CE, Annengers JF, Lairson DR, Reynolds TF. Methodological issues in estimating the Cost of Epilepsy. Epilepsy Res 2009; 33 : 39– 55.
25. Akinsulore A and Adewuya A. Psychosocial aspects of epilepsy in Nigeria. African J of Psychiatry 2010; 13: 351-56.
26. Sebasteian J, Adepu R, Keshava BS and Harsha S. Assessment of antiepileptic drugs usage in south indian tertiary care teaching hospital. Neurology Asia 2013; 18(2): 159-65.
27. Shackleton DP, Westendorp RG, Trenite DG and Vandenbrouke JP. Mortality in patients with epilepsy: 40 years of follow up in a dutch cohort study. J Neurol Neurosurg Psychiatry 1999; 66: 630-40.
28. Arulkumaran KSG, Palaniswamy S and Rajasekaran A. A study on drug use evaluation of anti-epileptics at a multispecialty tertiary care teaching hospital. Int J Pharmtech Res. 1(4): 1541-47.
29. Akhyani M, Ghodsi ZS and Toosi S, Daabghian H. Erythroderma : A clinical study 97 cases. BMC Dermatol 2005; 5:5: 51-58.
30. Wells BG, Dipiro JT, Schwinghammer T and Dipiro CV. Pharmacotherapy
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Sameer Siddiqui
GSVM Medical College, Kanpur
Dr Pooja Agrawal
GSVM Medical College, Kanpur
Dr Virendra Kushwah
Department of Pharmacology, GSVM Medical College, Kanpur (UP)
Dr Alok Verma
GSVM Medical College, Kanpur
Dr Amit Kumar
Rajkiya Medical College, Jalaun
Dr Himanshu Sharma
GSVM Medical College, Kanpur